Whole-Brain N-Acetylaspartate MR Spectroscopic Quantification: Performance Comparison of Metabolite versus Lipid Nulling

References

1. ↵
   Tallan HH, Moore S, Stein WH. N-acetyl-L-aspartic acid in brain. J Biol Chem 1956;219:257–64

   FREE Full Text
2. ↵
   Kreis R, Ernst T, Ross BD. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson Series B 1993;102:9–19

   CrossRefWeb of Science
3. ↵
   Jansen JF, Backes WH, Nicolay K, et al. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 2006;240:318–32

   CrossRefPubMedWeb of Science
4. ↵
   Baslow MH. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem Res 2003;28:941–53

   CrossRefPubMedWeb of Science
5. ↵
   Moffett JR, Ross B, Arun P, et al. N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007;81:89–131

   CrossRefPubMedWeb of Science
6. ↵
   Sager TN, Laursen H, Fink-Jensen A, et al. N-acetylaspartate distribution in rat brain striatum during acute brain ischemia. J Cereb Blood Flow Metab 1999;19:164–72

   CrossRefPubMedWeb of Science
7. ↵
   Arnold DL, de Stefano N, Matthews PM, et al. N-acetylaspartate: usefulness as an indicator of viable neuronal tissue. Ann Neurol 2001;50:823–25

   PubMedWeb of Science
8. ↵
   Ross BD, Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec 2001;265:54–84

   CrossRefPubMed
9. ↵
   Rigotti DJ, Inglese M, Gonen O. Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders. AJNR Am J Neuroradiol 2007;28:1843–49

   Abstract/FREE Full Text
10. ↵
    Li BS, Babb JS, Soher BJ, et al. Reproducibility of 3D proton spectroscopy in the human brain. Magn Reson Med 2002;47:439–46

    CrossRefPubMed
11. ↵
    Mathiesen HK, Tscherning T, Sorensen PS, et al. Multi-slice echo-planar spectroscopic MR imaging provides both global and local metabolite measures in multiple sclerosis. Magn Reson Med 2005;53:750–59

    CrossRefPubMedWeb of Science
12. ↵
    Hetherington HP, Pan JW, Mason GF, et al. 2D 1H spectroscopic imaging of the human brain at 4.1 T. Magn Reson Med 1994;32:530–34

    PubMedWeb of Science
13. ↵
    Spielman DM, Pauly JM, Macovski A, et al. Lipid-suppressed single- and multisection proton spectroscopic imaging of the human brain. J Magn Reson Imaging 1992;2:253–62

    PubMedWeb of Science
14. ↵
    Gonen O, Viswanathan AK, Catalaa I, et al. Total brain N-acetylaspartate concentration in normal, age-grouped females: quantitation with non-echo proton NMR spectroscopy. Magn Reson Med 1998;40:684–89

    PubMedWeb of Science
15. ↵
    Moonen CTW, Sobering G, van Zijl PCM, et al. Proton spectroscopic imaging of human brain. J Magn Reson 1992;98:556–75
16. ↵
    Inglese M, Ge Y, Filippi M, et al. Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis. Neuroimage 2004;21:1825–29

    CrossRefPubMedWeb of Science
17. ↵
    Rigotti DJ, Inglese M, Babb JS, et al. Serial whole-brain N-acetylaspartate concentration in healthy young adults. AJNR Am J Neuroradiol 2007;28:1650–51

    Abstract/FREE Full Text
18. ↵
    Benedetti B, Rigotti DJ, Liu S, et al. Reproducibility of the whole-brain N-acetylaspartate level across institutions, MR scanners, and field strengths. AJNR Am J Neuroradiol 2007;28:72–75

    Abstract/FREE Full Text
19. ↵
    Hu J, Javaid T, Arias-Mendoza F, et al. A fast, reliable, automatic shimming procedure using 1H chemical-shift-imaging spectroscopy. J Magn Reson B 1995;108:213–19

    CrossRefPubMed
20. ↵
    Li S, Dardzinski BJ, Collins CM, et al. Three-dimensional mapping of the static magnetic field inside the human head. Magn Reson Med 1996;36:705–14

    PubMed
21. ↵
    Gonen O, Grossman RI. The accuracy of whole brain N-acetylaspartate quantification. Magn Reson Imaging 2000;18:1255–58

    CrossRefPubMedWeb of Science
22. ↵
    Behar KL, Rothman DL, Spencer DD, et al. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med 1994;32:294–302

    CrossRefPubMedWeb of Science
23. ↵
    Traber F, Block W, Lamerichs R, et al. 1H metabolite relaxation times at 3.0 tesla: measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging 2004;19:537–45

    CrossRefPubMedWeb of Science
24. ↵
    Garwood M, DelaBarre L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J Magn Reson 2001;153:155–77

    CrossRefPubMedWeb of Science
25. ↵
    Ogg RJ, Kingsley PB, Taylor JS. WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B 1994;104:1–10

    CrossRefPubMedWeb of Science
26. ↵
    Hore PJ. Solvent Suppression. In: NJ Oppenheimer and TL James, eds. Methods in Enzymology: Nuclear Magnetic Resonance, Part A: Special Techniques and Dynamics. Vol.176 . San Diego: Academic Press;1989 :64–77.

    CrossRef
27. ↵
    Ebel A, Govindaraju V, Maudsley AA. Comparison of inversion recovery preparation schemes for lipid suppression in 1H MRSI of human brain. Magn Reson Med 2003;49:903–08

    CrossRefPubMed
28. ↵
    Hoult DI, Richards RE. The signal-to-noise ratio of the nuclear magnetic resonance experiment. J Magn Reson 1976;24:71–85

    CrossRefWeb of Science
29. ↵
    Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117(pt 1):49–58